RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Drivewire (Columbus) Neurovascular conductor

Product
Developers: Rapid Medical
Date of the premiere of the system: December, 2020
Branches: Pharmaceutics, medicine, health care

2020: Announcement of the neurovascular conductor of Drivewire (Columbus)

At the end of December, 2020 the Rapid Medical company which is engaged in development of sensitive neurovascular devices of the first class provided the new conductor of Driwerwire for vascular transactions with the managed disteel tip. Outside the USA the device extends under the name Columbus.

Conductors are the key components necessary for treatment of vascular damages of a brain, such as ischemic and hemorrhagic strokes. Usually doctors cannot control directly the movement of the wire conductor therefore they should enter the device several times, gradually changing its form for achievement of desirable result. Driwerwire is the first neurovascular conductor with the managed disteel tip which can change a course of the movement and a form at the request of the doctor. It allows the neurovascular surgeon to select the most effective and safe way to the struck anatomic section.

The first-ever managed neurovascular conductor of Drivewire (Columbus) for the most difficult transactions is released

Using Driwerwire doctors completely control the direction of the movement and a form of a tip of the wire conductor when it is in a vessel. It allows them to be guided and move ahead precisely on vascular network as brain, and on the periphery, thereby expanding possibilities of treatment using low-invasive intervention approaches.

File:Aquote1.png
Development of Driwerwire became effective cooperation. Now I can easily be guided in complex vascular network, changing a tip form directly in a vessel. It is impossible to execute similar with conductors, available in the market, - doctor Erez Nossek, the neurosurgeon from NYU Langone in New York noted. - I believe, this the technology first in own way will bring big benefit to patients with complex anatomic structure of vascular network and will expand treatment options available to them.[1]
File:Aquote2.png

Notes